Global Assisted Reproductive Technology Market
Assisted Reproductive Technology Market

Report ID: SQMIG35A3061

sales@skyquestt.com
USA +1 351-333-4748

Assisted Reproductive Technology Market Size, Share, and Growth Analysis

Global Assisted Reproductive Technology Market

Assisted Reproductive Technology Market Size, Share, Growth Analysis, By Offering (Hardware, Software, Service), By Vertical (Commercial, Infrastructure, Military & Defense, Residential, Public Facilities, Industrial), By System Type (Analog, IP, Hybrid), By Region-Industry Forecast 2026-2033


Report ID: SQMIG35A3061 | Region: Global | Published Date: July, 2025
Pages: 197 |Tables: 63 |Figures: 69

Format - word format excel data power point presentation

Assisted Reproductive Technology Market Insights

Global Assisted Reproductive Technology Market size was valued at USD 38.9 Billion in 2024 and is poised to grow from USD 42.13 Billion in 2025 to USD 79.73 Billion by 2033, growing at a CAGR of 8.3% in the forecast period (2026–2033).

The assisted reproductive technology market is witnessing significant growth driven by rising infertility rates, increasing awareness of reproductive options, and advancements in medical technologies.

The current advancements in ART technologies such as improved genetic screening, embryo culture methods and diagnostic instruments have been raising the efficacy and success rates of therapies.

Various organizations, such as the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology (SART), are working together to increase awareness about infertility treatment options.

Furthermore, several innovative types of research are undergoing in the field of culture media for ART. For instance, CooperSurgicals found that culture media with Granulocyte-macrophage Colony-Stimulating Factor (GM-CSF) contains essential nutrients required for embryo development and further enhance the transmission between the embryo and the endometrium, developing the essential environment for the pregnancy.

How is Artificial Intelligence Transforming the Assisted Reproductive Technology Market?

Artificial Intelligence (AI) plays a transformative role in the market by increasing accuracy, improving the success rate, and optimizing clinical decisions. AI is used in different stages of fertility treatment, ranging from fetal choices and semen analysis to IVF success prospects. By analyzing the huge dataset for the patient profile and treatment results, AI helps embryologists identify the healthiest embryos and recommend individual treatment protocols, which significantly improves the possibility of conception.

  • In 2024, a significant advancement came from a collaboration between a leading fertility clinic in Europe and a health tech startup that developed an AI-powered embryo grading system.

Market snapshot - 2026-2033

Global Market Size

USD 35.92 Billion

Largest Segment

In-Vitro Fertilization (IVF)

Fastest Growth

Artificial Insemination

Growth Rate

8.3% CAGR

Global Assisted Reproductive Technology Market 2026-2033 ($ Bn)
Country Share for North America Region 2025 (%)

To get more insights on this market click here to Request a Free Sample Report

Assisted Reproductive Technology Market Segments Analysis

Global assisted reproductive technology market is segmented by type, end-use, and region. Based on type, the market is segmented into in-vitro fertilization (IVF), artificial insemination, and others. Based on end-use, the market is segmented into fertility clinics, hospitals, and others. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

How do Fertility Clinics Support Market Scalability?

As per the global assisted reproductive technology market outlook, fertility clinics are the dominant segment in the market. These specialized centers offer dedicated reproductive services such as IVF, IUI, egg/sperm donation, and fertility preservation. Their dominance is driven by the availability of advanced infrastructure, skilled embryologists, and tailored patient care. Fertility clinics often integrate the latest technologies, including AI-based embryo selection and genetic screening, to improve success rates. Their patient-centric models, streamlined procedures, and ability to handle large volumes of ART cycles contribute significantly to their leadership in the market.

As per global assisted reproductive technology market forecast, hospitals are emerging as the fastest-growing segment in the market. Many multispecialty hospitals are expanding their fertility departments to meet rising demand and to offer ART services as part of integrated reproductive healthcare. This growth is particularly notable in developing regions where hospitals are the first point of care for most patients.

How do Technological Innovations Strengthen IVF’s Market Position?

In-vitro Fertilization (IVF) is the most widely used and dominant segment in the market. Its dominance stems from its high success rates, technological advancements, and its ability to address a wide range of infertility issues in both men and women. IVF procedures benefit from innovations such as preimplantation genetic testing (PGT), intracytoplasmic sperm injection (ICSI), and AI-based embryo selection, which further improve outcomes. IVF is also increasingly used by single parents and same-sex couples, contributing to its broad application and leading market share globally.

As per global assisted reproductive technology market analysis, artificial insemination is the fastest-growing segment due to its affordability, lower invasiveness, and ease of administration. This procedure is often the first-line treatment for unexplained infertility or mild male factor infertility and is widely accessible in both public and private clinics.

Global Assisted Reproductive Technology Market By Type 2026-2033 (%)

To get detailed segments analysis, Request a Free Sample Report

Assisted Reproductive Technology Market Regional Insights

What is Driving Growth of the Assisted Reproductive Technology Market in North America?

North America remains one of the leading regions in the market due to high awareness, favorable reimbursement scenarios, and widespread availability of advanced fertility clinics. The presence of skilled professionals, increasing acceptance of single-parent and same-sex family formations, and the rising age of first-time parents are key drivers in the region. Technological innovation and strong healthcare infrastructure further support ART adoption.

Assisted Reproductive Technology Market in the U.S.

The U.S. dominates the North America region, fueled by a high prevalence of infertility, increased demand for IVF and egg freezing, and a growing number of fertility centers. The country is also witnessing an uptrend in medical tourism, with international patients seeking access to state-of-the-art ART treatments. Regulatory support and increasing integration of AI and genetic testing are enhancing patient success rates.

Assisted Reproductive Technology Market in Canada

As per regional outlook, in Canada, the market is expanding steadily due to rising infertility rates and government support for select fertility treatments in certain provinces. Canada's progressive legal stance on same-sex parenting and surrogacy, along with growing public funding initiatives, is helping to make ART more accessible. The market is also benefiting from increased awareness and delayed family planning trends.

Why is Asia-Pacific the Emerging Hub for ART Services?

Asia-Pacific is experiencing rapid market growth due to population size, increasing cases of infertility, and evolving societal attitudes toward reproductive assistance. Many countries are investing in healthcare infrastructure and offering affordable fertility treatments, attracting medical tourism from both regional and international patients.

Assisted Reproductive Technology Market in Japan

As per regional analysis, Japan’s market is driven by one of the world’s highest average maternal ages and government initiatives to combat declining birth rates. Public subsidies for infertility treatments and growing investment in reproductive research are supporting ART growth. Clinics in Japan are also adopting AI to improve embryo selection and enhance IVF outcomes.

Assisted Reproductive Technology Market in South Korea

As per industry analysis, South Korea is proactively addressing its demographic challenges with strong government support for ART. The country provides subsidies for IVF and IUI, particularly for low-income families. Increasing social acceptance, improved treatment success rates, and public-private partnerships are accelerating the adoption of ART technologies.

How is Europe Advancing Ethical and Accessible ART Services?

Europe is a mature and regulated market, with widespread access to fertility services and robust government support in many countries. High healthcare standards, strong public awareness, and progressive laws regarding fertility treatments contribute to the market’s growth. However, regulatory variations across countries still influence patient access and treatment options.

Assisted Reproductive Technology Market in Germany

Germany maintains a strong market supported by quality clinical infrastructure and strict ethical guidelines. While some restrictions exist around embryo freezing and donor anonymity, technological innovation and increasing demand from older couples continue to support market expansion. Private funding and insurance are increasingly covering parts of ART procedures.

Assisted Reproductive Technology Market in the U.K.

The U.K. benefits from a well-structured ART framework regulated by the Human Fertilization and Embryology Authority (HFEA). Public awareness campaigns, NHS-funded fertility services in certain regions, and high clinical standards drive consistent market performance. The country is also a leader in embryo research and preimplantation genetic testing.

Assisted Reproductive Technology Market in Italy

Italy has undergone regulatory reforms in recent years, broadening access to ART services. Legal updates have increased eligibility for IVF and embryo cryopreservation. The demand is rising due to changing family structures, increased maternal age, and supportive private-sector clinics offering a range of advanced reproductive solutions.

Global Assisted Reproductive Technology Market By Geography, 2026-2033
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Assisted Reproductive Technology Market Dynamics

Assisted Reproductive Technology Market Drivers

Rising Infertility Rates Globally

  • One of the primary forces propelling the market is the increasing prevalence of infertility worldwide. Factors such as sedentary lifestyles, poor dietary habits, smoking, alcohol consumption, stress, environmental pollution, and the rising incidence of conditions like polycystic ovary syndrome (PCOS) and endometriosis are contributing to reduced fertility in both men and women. In urbanized areas, where these factors are more prevalent, the demand for assisted reproductive procedures has increased significantly. ART methods like IVF, IUI, and ICSI provide hope and options for couples struggling to conceive naturally, thereby accelerating market adoption.

Trend of Delayed Parenthood

  • Modern societal shifts have led to an increasing number of individuals and couples choosing to have children later in life due to career aspirations, higher education pursuits, financial planning, and personal preferences. This delay in childbearing significantly impacts fertility, particularly for women, whose ovarian reserve and egg quality decline with age. Consequently, many are turning to ART to conceive, resulting in a surge in demand for services like egg freezing, IVF with donor eggs, and fertility preservation. Clinics are responding with personalized and age-specific treatment protocols to cater to this growing demographic.

Assisted Reproductive Technology Market Restraints

High Treatment Costs and Limited Insurance Coverage

  • Despite the effectiveness of ART procedures, their high cost continues to be a significant barrier for many patients. Treatments like IVF can involve multiple cycles, which increases the financial burden on patients, particularly in countries where public health systems do not subsidize fertility care. In many regions, insurance coverage for ART is minimal or non-existent, making access difficult for middle- and lower-income groups. This financial barrier is a key reason why ART services remain underutilized in several parts of the world, despite rising infertility rates.

Ethical and Legal Concerns

  • The industry is subject to a complex landscape of ethical, cultural, and legal challenges that vary widely across regions. Issues such as embryo freezing, surrogacy, gamete donation, and same-sex parenting remain controversial in many societies. For instance, some countries restrict the use of donor eggs or prohibit commercial surrogacy altogether. Religious objections and concerns over the commodification of human reproduction also fuel debates around ART practices. These regulatory and cultural hurdles can delay treatment availability, create confusion for patients, and restrict international growth opportunities for fertility clinics.

Request Free Customization of this report to help us to meet your business objectives.

Assisted Reproductive Technology Market Competitive Landscape

The competitive landscape of the assisted reproductive technology industry is characterized by strong innovation, technological integration, and strategic expansion among key players. Leading fertility service providers and technology companies are focusing on enhancing clinical outcomes through AI integration, genetic screening, and automation of lab procedures.

As per market strategies, a notable example in 2024 is the strategic partnership between a global fertility clinic network and a reproductive AI startup to deploy AI-powered embryo grading and prediction systems across their clinics in Europe and North America. This collaboration aims to boost IVF success rates, reduce time-to-pregnancy, and personalize treatments using data-driven insights.

Startups are playing a transformative role in the assisted reproductive technology market by introducing agile, tech-driven solutions focused on personalization, accessibility, and success rate optimization. One emerging startup is leveraging AI-based embryo selection tools, helping fertility clinics increase implantation success by analyzing developmental patterns through time-lapse imaging.

  • TMRW Life Sciences (Founded in 2018): TMRW Life Sciences has revolutionized the way reproductive cells like eggs and embryos are stored and managed. The startup developed the world’s first automated, software-guided cryo-management platform for fertility clinics. Their system uses RFID tracking and robotics to improve the safety, accuracy, and transparency of frozen reproductive cell storage. This reduces the risk of manual error and improves chain-of-custody oversight, which is critical in fertility treatment processes. TMRW's technology is being adopted by leading IVF centers in the U.S. and Europe.
  • Alife Health (Founded in 2020): Alife Health is a San Francisco–based startup that uses artificial intelligence to assist fertility clinics in optimizing treatment plans and improving IVF outcomes. Its AI-powered platform analyzes millions of data points to help clinicians make personalized decisions regarding egg stimulation, embryo selection, and patient treatment strategies. Alife also offers patient-facing tools to help individuals understand the IVF process, track medications, and prepare for treatment. The company’s mission is to bring data-driven precision and transparency to the entire ART journey.

Top Player’s Company Profiles

  • Vitrolife AB
  • Merck KGaA
  • Ferring Pharmaceuticals
  • The Cooper Companies, Inc.
  • Progyny, Inc.
  • IVI-RMA Global
  • Boston IVF
  • Genea Limited
  • INVO Bioscience
  • Ovation Fertility
  • EMD Serono, Inc.

Recent Developments in Assisted Reproductive Technology Market

  • In April 2024, NewGenIVF, a fertility clinic network operating in Southeast Asia, completed a business combination with SPAC I Acquisition Corp. resulting in a Nasdaq listing under the ticker NIVF by April 4, 2024. This move secures capital for regional expansion and positions the company to capitalize on growing demand for ART and medical tourism in Asia-Pacific.
  • In November 2024, AI-driven fertility-tech startup Alife Health partnered with US Fertility one of the largest physician-owned fertility networks in the U.S. to pilot Embryo Assist™ in their labs. The cloud-based AI tool integrates with microscopes to capture embryo images, generate audit trails, and streamline embryo cataloging, aiming to enhance IVF precision and laboratory quality control.
  • In December 2024, Basecare Medical Group (China) and Jinghua Medical Group signed a strategic cooperation agreement to establish a new advanced assisted reproduction center in Shenyang. Basecare will deploy its AI-powered embryo culture systems, time-lapse incubators, and genetic diagnostics platforms, while Jinghua contributes to its clinical infrastructure. The partnership aims to create a comprehensive, intelligent IVF facility leveraging full-chain automation.

Assisted Reproductive Technology Key Market Trends

Assisted Reproductive Technology Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

As per SkyQuest analysis, key drivers of market growth include the rising global infertility rates, delayed family planning, technological advancements in ART procedures, increased awareness of fertility options, and supportive government initiatives and reimbursement policies. One of the latest tendencies in the assisted reproductive technology market is the mixing of telemedicine into fertility treatments. This permits digital consultations, far flung monitoring of sufferers' development, and follow-ups, improving convenience and accessibility for people seeking reproductive assistance. The high price associated with assisted reproductive technologies remains a full-size barrier for plenty of individuals, proscribing to get entry to these offerings.

Report Metric Details
Market size value in 2024 USD 38.9 Billion
Market size value in 2033 USD 79.73 Billion
Growth Rate 8.3%
Base year 2024
Forecast period 2026-2033
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • In-Vitro Fertilization (IVF), Artificial Insemination, Others
  • End-Use
    • Fertility Clinics, Hospitals, Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Vitrolife AB
  • Merck KGaA
  • Ferring Pharmaceuticals
  • The Cooper Companies, Inc.
  • Progyny, Inc.
  • IVI-RMA Global
  • Boston IVF
  • Genea Limited
  • INVO Bioscience
  • Ovation Fertility
  • EMD Serono, Inc.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Assisted Reproductive Technology Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Assisted Reproductive Technology Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Assisted Reproductive Technology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Assisted Reproductive Technology Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Assisted Reproductive Technology Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Assisted Reproductive Technology Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300

REQUEST FOR SAMPLE

Please verify that you're not a robot to proceed!
Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Assisted Reproductive Technology Market size was valued at USD 38.9 Billion in 2024 and is poised to grow from USD 42.13 Billion in 2025 to USD 79.73 Billion by 2033, growing at a CAGR of 8.3% in the forecast period (2026–2033).

The competitive landscape of the assisted reproductive technology industry is characterized by strong innovation, technological integration, and strategic expansion among key players. Leading fertility service providers and technology companies are focusing on enhancing clinical outcomes through AI integration, genetic screening, and automation of lab procedures. 'NewGenIVF', 'Basecare Medical Group', 'CooperSurgical, Inc.', 'Vitrolife AB', 'Merck KGaA', 'Ferring Pharmaceuticals', 'The Cooper Companies, Inc.', 'Progyny, Inc.', 'IVI-RMA Global', 'Boston IVF', 'Genea Limited', 'INVO Bioscience', 'Ovation Fertility', 'EMD Serono, Inc.'

One of the primary forces propelling the market is the increasing prevalence of infertility worldwide. Factors such as sedentary lifestyles, poor dietary habits, smoking, alcohol consumption, stress, environmental pollution, and the rising incidence of conditions like polycystic ovary syndrome (PCOS) and endometriosis are contributing to reduced fertility in both men and women. In urbanized areas, where these factors are more prevalent, the demand for assisted reproductive procedures has increased significantly. ART methods like IVF, IUI, and ICSI provide hope and options for couples struggling to conceive naturally, thereby accelerating market adoption.

Integration of Artificial Intelligence and Automation: AI and machine learning technologies are rapidly transforming the ART landscape by improving precision, personalization, and clinical success rates. Tools like AI-driven embryo selection, automated sperm analysis, and ovarian stimulation prediction models are helping embryologists make better informed decisions and reduce human error. AI algorithms analyze vast datasets to identify subtle indicators of embryo viability that are often missed by the human eye.

What is Driving Growth of the Assisted Reproductive Technology Market in North America?
AGC3x.webp
Aisin3x.webp
ASKA P Co. LTD3x.webp
BD3x.webp
BILL & MELIDA3x.webp
BOSCH3x.webp
CHUNGHWA TELECOM3x.webp
DAIKIN3x.webp
DEPARTMENT OF SCIENCE & TECHNOLOGY3x.webp
ETRI3x.webp
Fiti Testing3x.webp
GERRESHEIMER3x.webp
HENKEL3x.webp
HITACHI3x.webp
HOLISTIC MEDICAL CENTRE3x.webp
Institute for information industry3x.webp
JAXA3x.webp
JTI3x.webp
Khidi3x.webp
METHOD.3x.webp
Missul E&S3x.webp
MITSUBISHI3x.webp
MIZUHO3x.webp
NEC3x.webp
Nippon steel3x.webp
NOVARTIS3x.webp
Nttdata3x.webp
OSSTEM3x.webp
PALL3x.webp
Panasonic3x.webp
RECKITT3x.webp
Rohm3x.webp
RR KABEL3x.webp
SAMSUNG ELECTRONICS3x.webp
SEKISUI3x.webp
Sensata3x.webp
SENSEAIR3x.webp
Soft Bank Group3x.webp
SYSMEX3x.webp
TERUMO3x.webp
TOYOTA3x.webp
UNDP3x.webp
Unilever3x.webp
YAMAHA3x.webp
Yokogawa3x.webp

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Feedback From Our Clients